The way I read that, they are not creating cannabinoids. They're using enzymes to reorganize molecules into completely different compounds that they call cannabosides that mimic the effects of some cannabinoids. It's an entirely different technology that may or may not be effective. There's no way to know without trial and error whether these new compounds will have the same qualities as the cannabinoids they claim to mimic. I don't see them as being a direct competitor to InMed.
It also seems a little suspect that they claim that their big advantage is to be able to remove any trace of THC so that their product is non-psychoactive. I don't think they fully understand the market. Some THC combined with CBD or other cannabinoids may actually be beneficial in treating certain conditions.
News 
Market Data 
Discover 
AI
